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Abstract
Background: Neglected tropical diseases (NTDs) affect more than one billion people living in vulnerable
conditions. In spite of initiatives recently contributing to fill NTDs gaps on national and local prevalence and
distribution, more epidemiological data are still needed for effective control and elimination interventions.
Main text: Mozambique is considered one of the countries with highest NTDs burden although available
data is scarce. This study aims to conduct a systematic review on published available data about the burden
and distribution of the different NTDs across Mozambique since January 1950 until December 2018. We
identified manuscripts from electronic databases (Pubmed, EmBase and Global Health) and paper publications
and grey literature from Mozambique Ministry of Health. Manuscripts fulfilling inclusion criteria were: cross-
sectional studies, ecological studies, cohorts, reports, systematic reviews, and narrative reviews capturing
epidemiological information of endemic NTDs in Mozambique. Case-control studies, letters to editor, case
reports and case series of imported cases were excluded. A total of 466 manuscripts were initially identified
and 98 were finally included after the revision following PRISMA guidelines. Eleven NTDs were reported in
Mozambique during the study span. Northern provinces (Nampula, Cabo Delgado, Niassa, Tete and Zambezia)
and Maputo province had the higher number of NTDs detected. Every disease had their own report profile:
while schistosomiasis have been continuously reported since 1952 until nowadays, onchocerciasis and
cysticercosis last available data is from 2007 and Echinococcosis have never been evaluated in the country.
Thus, both space and time gaps on NTDs epidemiology have been identified.
Conclusions: This review assembles NTDs burden and distribution in Mozambique. Thus, contributes to the
understanding of NTDs epidemiology in Mozambique and highlights knowledge gaps. Hence, the study
provides key elements to progress towards the control and interruption of transmission of these diseases in
the country.
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Helminth, Trachoma, Leprosy
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: berta.grau@isglobal.org
†Carmen Maroto, Alcino Ndeve and Francisco Saute contributed equally to
this work.
1ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain
2Centro de Investigação em Saúde da Manhiça (CISM), Maputo, Mozambique
Full list of author information is available at the end of the article
Grau-Pujol et al. Infectious Diseases of Poverty           (2019) 8:103 
https://doi.org/10.1186/s40249-019-0613-x
Multilingual abstracts
Please see Additional file 1 for translations of the ab-
stract into the five official working languages of the
United Nations.
Background
Neglected tropical diseases (NTDs) are a group of diseases
mainly caused by a virus, bacterium, protozoon or helminth.
Even though they have distinct biological and transmission
features, they all affect the most vulnerable populations, pri-
marily in low socio-economic countries — one billion
people annually [1]. NTDs lead to elevated morbidity, child-
maternal health complications and impaired child develop-
ment. Hence, they affect the quality of life and contribute to
a cycle of poverty in endemic populations [2, 3].
NTDs are targeted in the context of the Sustainable De-
velopment Goal (SDG) 3.3: “To end the epidemics of Ac-
quired Immunodeficiency Syndrome (AIDS), tuberculosis,
malaria, NTDs, hepatitis, water-borne diseases and other
communicable diseases by 2030.” [4] Unfortunately, the
scarcity of epidemiological data for NTDs hampers the
implementation of control and elimination activities in
many endemic countries [5]. Epidemiological information
about the presence of NTDs, including spatial mapping, is
key for effective implementation of interventions [2]. In
spite of public and private initiatives recently contributing
to fill NTDs gaps on national and local prevalence and
distribution, more epidemiological data are still needed
for effective control and elimination interventions.
Mozambique is a country in sub-Saharan Africa that con-
sists of an area of 786 000 km2 with a population of 29 mil-
lion [6], 46.1% of them living with poverty conditions [7].
Although Mozambique is one of the countries with the
highest total burden of NTDs [8, 9], very limited data about
the burden and distribution of these diseases is available [1].
A comprehensive and systematic review of scientific lit-
erature on NTDs is a first step to understand where these
diseases may be present and what populations are more
exposed in the country. This will allow us to identify exist-
ing gaps in disease mapping. Thus, we aim at reviewing
and assembling published available data about the preva-
lence and distribution of the different NTDs across
Mozambique since 1950. The outcome could guide future
Mozambican and international research, and will also
support and influence future health policy decisions in this
country which may be extrapolated worldwide.
Main text
Methods
Search strategy
This review is based on the Preferred Reporting Items
for Systematic Reviews and Meta-Analysis (PRISMA)
guidelines (Additional files 2 and 3). We conducted an
electronic literature search using EndNote X7.8
throughout the following electronic databases: Pubmed/
MEDLINE, EmBase and Global Health. We did not apply
restrictions to language of publication. The results were
limited in the search string to articles published from Janu-
ary 1950 to December 2018. Five NTDs recently considered
by the World Health Organization (WHO) (chikungunya,
mycetoma, chromoblastomycosis, scabies and snakebite)
were not included. Chagas was not included in the search
due to its geographical distribution limited to Latin
America. The search terms used are found in Additional
file 4. We conducted additional search on paper publica-
tions and grey literature (conference proceedings, abstracts,
masters and doctoral theses) available in Mozambique
Ministry of Health library. We also extended the search to
the reference lists of ascertained articles to identify more
publications that met searching criteria. To be eligible for
inclusion, studies had to be cross-sectional studies, eco-
logical studies, cohorts, reports, systematic reviews, and
narrative reviews capturing information related to epidemi-
ology of endemic NTDs in Mozambique. Case reports and
case series were considered for inclusion if studies con-
firmed national case location and they were not imported
cases. We excluded case-control studies, letters to editor
and case reports and case series of imported cases. Studies
with participants based out of the country of Mozambique
and studies based on mathematical modelling of epidemio-
logical data were also excluded. No restrictions were made
with diagnosis strategy.
Study selection
The methods used in selecting manuscripts are provided
in Fig. 1.
Results
Demographic trends
Figure 2 illustrates the trends in publications accomplish-
ing the inclusion criteria. Until 2004, the number of arti-
cles that provide information on the prevalence or
incidence of NTDs in Mozambique was quite low, with a
minimum and a maximum of one article and 11 articles in
5 years respectively. The period with lower number of
publications coincide with the Mozambican Independence
War (1964–1974). The last 13 years, this numbers had
steadily increased. In addition, from 2015 onwards, a
higher variety of NTDs are studied in the country coincid-
ing with the international recognition of NTDs as a public
health priority in low and middle income countries, as
was highlighted in the London Declaration of NTD in
2012. The publication trend for each NTD between 1950
and 2018 has its own character, while we can find studies
on Human African trypanosomiasis in 1952 and the last
published about it was in 1987, no studies on cysticercosis
are found until 1990. Conversely, we found schistosomia-
sis studies from 1957 until nowadays.
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Considering the data collection time, the Northern
provinces (Nampula, Cabo Delgado, Niassa and Tete),
Zambezia and Maputo and Maputo city had the highest
number of NTDs idenified along the study span. For the
last 10 years, Gaza, Manica and Inhambane are the pro-
vinces with less NTDs reported. During this period, viral
NTDs have been observed in the north of the country and
Maputo province, helminth’s NTDs in the northern
provinces, bacterial NTDs in all of them while proto-
zoan NTDs were not reported. Figure 3 illustrates the
reported distribution of NTDs per province in
Mozambique during the last 10 years. The information
shown in the map is limited by the few publications
available per disease.
Fig. 1 Selection of the sources included in the review
Fig. 2 Number of NTDs publications in Mozambique during 1950–2018 accepted by full-text, displayed every five years. NTDs: Neglected tropical diseases
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Neglected viral infections
Dengue fever The first ever documented case of dengue
virus transmission was caused by a serotype 3 in Pemba
Province in October 1984. After a peak in December
1984, the outbreak concluded in March 1985. Although
there is limited information regarding the extent of the
epidemic, it is estimated to have affected 45% of Pemba
province population, with no observable differences in
gender, age or neighborhood [10–12]. Cases were
confirmed using hemagglutination-inhibition (HI), com-
plement fixation (CF) and IgM antibody capture
enzyme-linked immunosorbent assay (ELISA) [13]. In
2014, thirty years after the first documented outbreak,
another dengue outbreak occurred in Pemba and Nam-
pula. A total of 193 clinically suspected dengue cases
were detected, of those three were detected with reverse
transcriptase polymerase chain reaction (PCR) in sera
and 97 tested positive for dengue virus (DENV) NS1
antigen or anti-DENV IgM antibody. No further cases of
Fig. 3 NTDs distribution in Mozambique per province. a, provincial map for each specific NTD identified per province during 2008–2018 in Mozambique,
b, number of NTDs identified per province during 2008–2018 in Mozambique. These maps are original, build with R (http://www.R-project.org/).
Cartographic resources were obtained from GADM (www.gadm.org), epidemiological data was obtained from the manuscripts reviewed. See Additional
file 5. NTDs: Neglected tropical diseases. *Only national data but not provincial data is provided
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dengue have been reported in Mozambique after this
outbreak.
Rabies The number of human rabies cases notified de-
creased from 48 in 1978 to five in 1981 with a mild increase
in 1982. This tendency was suggested to be related to ani-
mal vaccination, which followed the opposite trend. From
1978 until 1982, the mean annual incidence of rabies in
Mozambique was 0.2/100000 inhabitants with a total of
123 cases registered. Tete was the province with more hu-
man rabies cases notified (22 cases) and Niassa with fewer
cases (four cases) [14]. Few years later, the number of hu-
man rabies notifications sharply increased in the country
[15]. The annual average of cases from 2008 until 2010 was
40.3, and according to the World Animal Health Informa-
tion System 72 cases occurred in 2011. Maputo province
had the highest human rabies case number per inhabitant,
followed by Zambezia and Nampula provinces. During this
period, case confirmation was conducted with fluorescent
antibody test (FAT) at Central Veterinary Laboratory [15].
In 2014, there was an outbreak of 14 cases in Maputo and
Matola cities and Boane neighbouring district. All cases
were clinically detected with no laboratory confirmation,
they were recently bitten by a dog and they were admitted
in Maputo Central Hospital [16].
Neglected bacterial infections
Trachoma Paulo et al. (1984) [17] conducted a trach-
oma survey by clinical examination in both schoolchil-
dren and community population in a village in Mueda,
northern Mozambique. The overall prevalence in school-
children was 34%. The prevalence in the community,
during clinical visits for eye claims in two neighbour-
hoods of the village was 67 and 50%. Cairncross and
Cliff (1987) [18] conducted a study in two villages in the
same area. One was water supplied and observed a
trachoma prevalences of 19%, and the other was non-
water supplied, with 38% trachoma prevalence. In both
villages, most positive cases were adults (67%) and they
detected some clustering of cases by household. Next
epidemiological data available on trachoma in
Mozambique is not until 2012–2015, when Abdala et al.
(2017) evaluate 137 districts. They observed a trachoma-
tous inflammation-follicular prevalence > 10% in
children 1–9 years old in 20 districts and a trichiasis
prevalence ≥0.2% in > 15 years old in 34 districts [19].
Leprosy From 1996 to 1998 there was a decline on new
leprosy cases passively identified. However, in 1998,
Mozambique was still the sixth country most affected by
leprosy in the world with 2412 cases detected (3.4 cases
per 10 000 people) [20]. After the implementation of ac-
tive case detection in 1999, the number of new cases
detected increased by 57% (3791 new cases). Niassa,
Cabo Delgado and Nampula had the highest prevalence.
Concretely, Nampula province, with 19% of the country
population, had 55% of leprosy cases. While passive case
finding at clinics attracted a higher proportion of
women, active case finding significantly detected
younger patients (< 15 years old) and paucibacillary
cases: patients with less than six patches with clear loss
of sensitivity and/or one enlarged peripheral nerve [20,
21]. The annual number of new leprosy cases at a
national level in 2003 was 5907, which decreased until
achieving the elimination goal at the beginning of 2008.
Nevertheless, at that time Mozambique was still among
the 17 countries that accounted for 94% of the new cases
detected globally, with ≥1000 new cases per country. In
2010 there was small increase in the cases detected
(1207 new cases) compared to 2009 (1191 new cases).
Following this number, in 2012, the cases decreased to
758. After a 2 year of no cases reporting, in 2015 cases
raised again to 1335 in 2015 and to 1926 in 2017, with
243 and 293 new cases identified with grade-2
disabilities (28 of them where children) [22–33].
Neglected protozoal infections
Human African trypanosomiasis In Mozambique, only
Trypanosoma brucei rhodesiense causes human African
trypanosomiasis (HAT). The first case in the country
was identified in Tete in 1909, confirmed by microscopy
[34, 35]. .In 1945, it was created the Mission to Combat
Trypanossomiasis (MCT) and active case finding was
implemented. That year, 180 cases were identified in the
north and northeast of the country. During 1946 and
1948 the Metangula epidemic occurred in Niassa, with
654 cases detected, a mean of 218 cases per year. After
that, the number of national cases decreased to 184 in
1949. However, another epidemic occurred during 1952
to 1954 in Mocímbua da Praia, Cabo Delgado, with 705
cases detected. The MCT responded with a chemo-
prophylactic campaign in that region, decreasing the en-
demic index to 0.17 cases per 1000 inhabitants in 1956,
compared to 0.4 cases per 1000 inhabitants in 1954.
Thus, 1956 was the year with fewer cases (127 cases)
since 1945: 89 cases in Cabo Delgado, 30 cases in Tete
and eight cases in Nampula. However, in 1957, there was
an increase of 94 annual cases detected (221 cases de-
tected), with 141 cases in Cabo Delgado, 52 cases in Tete,
27 cases in Nampula and one case in Niassa [35–42].
.Nevertheless, there was 70% decline in 1959, with 63
cases, maintained with a mean of 46 the following 20
years. During 1975–1984, after the Mozambican War of
Independence (1964–1974), a total of 739 cases were iden-
tified (87% of cases in Tete), and from 1982 onwards there
was an increasing number in Niassa and Cabo Delgado
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[35, 43]. The prevalence of the disease was always re-
ported higher in adult men. All suspicious cases had at
least one of these symptoms: fever, adenopathy, oedema
and loss of weight. In this way, all cases reported from
1953 onwards, were clinically identified and confirmed
microscopically with blood smear or thick blood smear
and CSF. Eighty per cent of the patients were diagnosed in
the second phase of the disease (parasite invaded the cen-
tral nervous system) and they were identified by trypano-
somes in CSF or CSF with more than 25mg of proteins/
100ml liquor. Regarding treatment, 4% of the patients in
Mozambique were identified as resistant to melarsoprol
[43]. More recent, in 2002 and 2004 a case each year was
reported in the context of WHO network for HAT
elimination, but no cases have been reported later on [44].
Helminths infections
Onchocerciasis The situation of onchocerciasis in
Mozambique was unknown until 1996, when the disease
was confirmed in Zambezia and Tete. In 1998,
Mozambique Ministry of Health in conjunction with the
World Health Organization selected 60 villages from Cabo
Delgado, Niassa, Tete and Zambezia (provinces closer to
the borders with endemic countries) with high presence of
risk factors for onchocerciasis: (i) close proximity to rivers
and rapids, (ii) isolated village and (iii) first river line com-
munities. Thirty to fifty people from the community older
than 20 years old with agricultural activities were selected
for screening through nodule inspection. For communities
bigger than 800 people they invited to participate the popu-
lation closer to the river. Thus, 3126 people were enrolled:
1769 men and 1357 women. The prevalence of the four
provinces was under 2%, with higher prevalence for men
and for Niassa and Zambezia provinces. No other provinces
were examined [45–47]. In 2001, a Rapid Epidemiological
Mapping of Onchocerciasis (REMO) [48] survey in the
north of the country observed 50 positive cases from
Inhambane, Tete, Niassa, Zambezia or Cabo Delgado. In
2007, another REMO survey observed 61 positive cases
from Niassa, Cabo Delgado, Zambezia or Tete. Manica,
Sofala and Nampula were also surveyed in 2001 but no
cases were found and they were not examined in 2007.
Lymphatic filariasis No cases of lymphatic filariasis
(LF) were identified in Mozambique until the campaign of
the Mission to Combat Trypanosomiais did in 1953. They
detected 14 cases (0.26% of prevalence) ofWuchereria bran-
crofti infection in blood in the human African trypanosom-
iasis endemic area (Tete, Cabo Delgado, Niassa and
Nampula) [49]. During 1959–1960, Nampula showed a
prevalence of W. brancrofti infection of 5%, Cabo Delgado
6.7%, Manica and Sofala 10.9%, Tete 19.3% and Zambezia
5.4% (1959) and 8% (1960) [50]. Concretely, 87 of adult
cases and 21 child cases ofW.brancrofti infection were iden-
tified from 1420 people examined in Zambeze valley during
that period [51]. No more data was available until 1990,
when a study conducted in Pemba provincial hospital
showed a prevalence of infection of 12%, with 8.1% in
people from Pemba city and 19.7% in people living outside
the city. Although a higher number of women were exam-
ined (57%), men represented 63% of the cases. In addition,
prevalence of infection in men showed to increase signifi-
cantly with age, with higher prevalence in men between 21
and 30 years old [52]. In 1998, REMO campaign also benefit
the identification of LF cases: they identified 21 cases of
hydrocele and four cases of lymphedema in Cabo Delgado,
Tete and Zambezia. During the period 1995–2000, hospital
histories in Pemba (Cabo Delgado) showed 1300 cases iden-
tified, which 99.5% of those had hydroceles and the only
cases of lymphedema identified were women. In addition,
there was a lower frequency of cases in people < 15 years
old [53]. In 2009, Mozambique was still one of the 39 Afri-
can countries that are endemic for LF, with 16 million
people estimated at risk and two million infected; Cabo Del-
gado and Nampula were the provinces with higher risk [54].
Dracunculiasis All endemic countries for dracunculiasis
are in sub-Saharan Africa. Nevertheless, the Inter-
national Comission for the Certification of Dracunculia-
sis Eradication held in 2007 certified Mozambique as a
country free of transmission [55].
Cysticercosis There is limited available data on cysticer-
cosis in Mozambique. An initial cross-sectional study in
Tete district showed absence of Taenia infection exam-
ined microscopically by Ritchie-Willies technique. But in
1968, the first reported post-mortem neurocysticercosis
case was incidentally detected, in association with rabies.
Few years later, in 1999, the first clinical neurocysticerco-
sis case was reported in Maputo Central Hospital [56, 57].
Few cross-sectional seroepidemiology studies showed
prevalences of 20% in 1994 and 15% in 2009 in Tete
[56–58], and 12.1% in 1999 and 20.8% in 2003 in Maputo
[57, 58]. Only one case was detected by faecal examination
in Maputo in 2003 [57]. In Angonia district, Tete, 51% of
the seropositive people of the district presented neuro-
cysticercosis in 2007 and neurocysticercosis-associated
epilepsy and headache was present in 5% of the
population [59–61].
Schistosomiasis The first case of urinary schistosomia-
sis was reported in Nampula in 1904 as “tropical haema-
turia” [62, 63]. Nevertheless, the first schistosomiasis
national survey was not performed until 1952–1957 by
the Institute of Tropical Medicine in Lisbon. Schisto-
soma haematobium was found in all districts and the
district rates ranged between 40 and 80%, while the
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distribution of S. mansoni was as extensive but missing
in Cabo Delgado [64]. In fact, settlers with less than a
year of residence had schistosome parasite rate of 2.6%
in 1956 [65]. In 1961, S. haematobium prevalence rates
under 50% were only reported in the districts of Maputo
and Tete, whereas in Niassa it was over 70% and in
Zambezia and Nampula over 80% [62, 66]. S. mansoni
was determined at the same survey during that period
but prevalence was moderate-low (from < 10 to 30%)
and not detected in 28 of the 80 districts. S. mansoni
was only over 12% in Inhambane (19%) and Tete (18.2%)
[66]. In 1985, a study in primary schools showed a
prevalence of 23.4% for S. haematobium and 4.4% for
S.mansoni [67], and the urinary form was always found
far higher than intestinal schistosomiasis [62]. Taking
that into consideration, Gama Vaz (1993) observed that
7.5% of urinary schistosomiasis patients in Mozambique
develop bladder carcinoma, and 59% of them developed
squamous cells’ carcinoma [68]. In 1994, Taquinho et al.
(1994) conducted a study with 1240 participants from
one to 70 years old in Boane, Maputo province, and ob-
served that 40.7% had urinary schistosomiasis, and
74.5% of infected people were between 5 and 19 years
old. In 1998, a study of 434 schoolchildren from 6 to 16
years old randomly selected from random selected
schools of the city in Maputo showed a lower overall
prevalence of urinary schistosomiasis (11.3%) [69],
nevertheless only a sample from each participant was
evaluated. In 2005–2007, Augusto et al. (2009) updated
the national data available on Schistosomiasis. They ob-
served 47% for S. haematobium and 1% S. mansoni over-
all. The prevalence of S. haematobium increased slightly
with age, reaching a peak in the schoolchildren 10–14
years (47.4%) and 45.3% in children > 14 years of age.
The highest S. haematobium prevalence was in the
northern provinces (Cabo Delgado, Niassa, Nampula,
and Zambezia) and in certain provincial capital cities.
The lowest S. haematobium prevalences were in Inham-
bane (19.9%), Gaza (21.4%) and Tete Province (33.4%)
[70]. By 2012, Mozambique was considered highly en-
demic for schistosomiasis (> 50%), with Ghana, Liberia
and Sierra Leone [71]. Indeed, the last cross-sectional
study in northern Mozambique, in 2014, still reflected a
prevalence of urinary schistosomiasis of 59.1% [72]. The
diagnostic method used was not described in some of
the reviewed studies. In those in which it is described, a
wide variety of diagnostic methods is used, including
urine filtration for S. haematobium and different micros-
copy techniques such as Ritchie and Kato-Katz
techniques for S. mansoni detection.
Soil-transmitted helminthiasis The first data available
on soil-transmitted helminths (STH) infections appears in
1958. De Morais (1958) [73] conducted a cross-sectional
study in Inhaca island, Maputo, with 80 people aged from
3 to 30 years old and they found very high prevalences for
Ascaris lumbricoides and Trichuris trichiura (86.3 and
52.5% respectively). A latter cross-sectional study was per-
formed in Maputo district in 1961 and out of 20 Inhaca
participants showed that 18 of them were infected with A.
lumbricoides, five with Ancylostoma duodenale and one
with Strongyloides stercoralis infection. STH prevalence
observed in the complete study in Maputo district in 1961
(420 participants) was also headed by A. lumbricoides
(57.61%), followed by A. duodenale (16.4%) and S. stercor-
alis (1.2%) [74]. In Maputo city, a cross-sectional study be-
fore conducting an evaluation of a sanitation programme
in 97 households (244 people) in 1987 showed 23% of
STH infection with a higher infection in 5 to 15 years old
(35%) [75]. Enosse et al. (1995) [76] conducted household
feaces collection in 30 clusters of households from Infu-
lene valley (Maputo city rural area) and Maholas (Maputo
city semi-urban area) and detected STH prevalence still
headed by A. lumbricoides (17.1%), followed by T. tri-
churia (15.4%), A. duodenale (6.4%) and S. stercoralis
(1.7%). However, the STH with highest prevalence in
Maputo Central Hospital in children between 1.5 and
48.2months of age in 2009 was T. trichuria (6.5%), while
the prevalence of A. lumbricoides was only 2.2% [77].
Three studies were conducted in the city of Beira. The
first one, in 2004, disclosed that helminths infections were
highly prevalent in the suburban Beira inhabitants of all
ages. From 497 people, 95.5% in children aged 2–6 years
were infected by STH; 97% in aged 7 to 15 and 76.4% in
aged > 15 years old. Concretely, T. trichuria was the most
common parasite, whereas A. lumbricoides was less com-
mon and hookworms were rare [78]. The second study ex-
amined all samples by direct smear, formal-ether
concentration (FEC), Kato-Katz smear, Baermann method,
coproculture and real-time PCR and found that 96% of
the participants (n = 303) from an informal settlement,
Inhamudima, were infected by at least one STH in 2007,
and almost half of them by three STH or more. T. tri-
churia was the most abundant (93%), followed by A. lum-
bricoides (56%), S. stercoralis (48%) and hookworm (38%).
The third study, conducted in 2013, detected lower spe-
cific prevalences by STH ranging between 35 and 53%
[79]. In the northern provinces of Mozambique, three
cross-sectional studies were performed. Firstly, in contrast
to Maputo and Beira, Pinhão (1965) [80] observed the
highest prevalence for A. duodenale (12%), and lower for
A. lumbricoides (3–5%) and S. stercoralis (0–2%) in Tete.
In addition, Casmo et al. (2014) [72] during 2005–2007
detected 31.3% of hookworm prevalence in Cabo Delgado,
Niassa and Nampula. Moreover, a survey in 3 Nampula
schools in 2009, A. duodenale was also the STH with main
prevalence (18.9%) [81]. All prevalences were determined
by different microscopy techniques; while most used
Grau-Pujol et al. Infectious Diseases of Poverty           (2019) 8:103 Page 7 of 11
Ritchie and Willies techniques, only the study conducted
by Meurs et al. (2017) [82] in Inhamudina used the
Baermann technique to detect S. stercoralis.
No articles or reports meeting our criteria were
found for buruli ulcer, yaws, leishmaniasis, fascioliasis
and echinococcosis.
Discussion
Mozambique has been reported to be endemic for 11
NTDs since 1950. Every NTD has had their own profile in
the country: while some are widely spread (e.g. soil-
transmitted helminths), others are only localized in some
areas of the country (e.g. HAT). Northern provinces (Cabo
Delgado, Nampula, Niassa and Tete), the north-central
province (Zambezia) and Maputo province and city are
the regions with more NTDs’ evidence and might be the
most affected areas. Ecological and demographic condi-
tions could partly explain that. The north has higher rain-
fall and higher temperatures resulting in a sub-humid area
and the center has higher number of floods, whereas the
south is more arid [83]. Moreover, north and center are
the areas with highest poverty indices and highest propor-
tion of usage of unsafe water and sanitation [84]. Further-
more, Nampula, Zambezia and Maputo are the provinces
with highest population density [85].
However, data are missing on both space and time scales.
A few regions do not hold data for some NTDs, which
does not imply no NTDs transmission. A possible explan-
ation is that resources to generate evidence are allocated to
either higher risk regions for NTDs or regions with more
technical facilities [2], for instance studies based in Maputo
city or Maputo Central Hospital. Fortunately, the national
program is running specific programs for LF, schistosomia-
sis and STH at a district level that will provide new data on
prevalence and distribution soon. However, for those dis-
eases with no current national program, their epidemio-
logical status is unknown and the reliable epidemiological
data is limited. It is the case of cysticercosis or onchocercia-
sis, which have no data available since 2007 even though
both are considered endemic by WHO [86]. Some NTDs,
such as echinococcosis, have never been evaluated in Mo-
zambican territory. Along these lines, we also observed that
during the period of the Mozambican War of
Independence the number of publications declined. After
this event, data on some diseases was missing for several
years: during 20 years for HAT and 30 years for trachoma,
until later studies showed that they were still present.
Moreover, national and international disease priorities
also affect surveillance and research resources allocation.
Many NTDs have a regional relevance but are not widely
distributed [3]. Considering that low-income countries
usually have restricted resources for health programs [2],
the resilient epidemic of HIV/AIDS, tuberculosis and mal-
aria in sub-Saharan Africa could overcome NTDs rank
[87, 88], .In fact, it has been observed that these diseases
dominate infectious diseases research whereas global
NTDs research intensity is still low [88, 89].
On the other hand, the use of diverse diagnostic tech-
niques for the same disease makes the data difficult to
harmonize and compare among the studies across space
and time. Studies were conducted using tests with differ-
ent sensitivities, especially for infections detected by mi-
croscopy in feces samples, such as S. mansoni and STH.
In particular, only one study used Baermann technique
for S. stercoralis identification, the most sensitive mi-
croscopy test nowadays for this parasite [90]. In addition,
some surveys identified the NTD as a secondary effect of
the main study endpoint, thus, the epidemiological par-
ameter could be biased by report or measurement.
Furthermore, this review has their own limitations.
From 306 records identified, 17% could not be acquired
neither online nor on paper. Moreover, some studies tar-
geting NTDs have to be discarded because the sample
size and study design was unclearly defined. Thus, the
remaining records were few. In addition, since data was
from different areas of the country, several years apart
and diagnosed with different sensitivity tests, to conduct
a meta-analysis was unfeasible. However, the NTDs epi-
demiological records assembled for the first time in the
results of this review could guide the future directions of
NTDs research and health programs.
Enhanced surveillance in Mozambique is needed to
evaluate the presence and distribution of the diverse
NTDs in the country, to assess possible increase or re-
emergence of NTD infection in the country, and to
inform policy makers to target control and elimination
strategies. For a reliable surveillance, to map risk areas
where NTD data is unavailable is essential, especially if
elimination is not certified. We recommend the use of
remote sensing predictors of disease ecology and accur-
ate mapping to tackle NTDs hotspots, primarily after the
last natural disasters recently occurred in the country. In
addition, we prompt the need to develop and use sim-
pler field test tools, especially for S. stercoralis. On top
of that, we also support the integration of NTDs pro-
gram in one when possible (e.g. MDA or vector control),
the partnership among national health programs across
Box 1 NTDs’ research and control programme gaps in
Mozambique that could enhance national NTDs programs
Mozambique NTDs’ research and control needs
- To enhance NTDs’ surveillance and to use prediction mapping
in Mozambique to describe NTDs’ presence and distribution
around the country.
- To develop and to utilize simpler field testing tools.
- To integrate national NTDs programs’ strategies, such as mass
drug administration and vector control.
- To create a trans-boundering alliance for NTDs programs among
neighbouring countries.
- To incorporate a one health approach.
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countries to control trans-boundering diseases (e.g for
HAT), and the integration of animal health – the One
Health approach. This could diminish logistical and
financial effort, provide data for populations difficult to
access and improve NTDs’ surveillance [2, 9].
Higher surveillance in NTDs would improve people’s
life. But it would not only decrease NTDs infections, it
would also diminish other health complications, such as
HIV, epilepsy or cancer. As example, genital schistosom-
iasis has been observed to quadruple the chances of HIV
infection [91], neurocisticercosis is associated with 30%
of the global epilepsy [92], and S. haematobium control
has been associated with bladder cancer decline [93].
Hence, identifying its infection and reducing transmis-
sion could enhance other population health conditions
and reduce national health spending.
Conclusions
This manuscript reviews the known prevalence and dis-
tribution of the most relevant NTDs in Mozambique
since 1950 until 2018. All NTDs had very different pro-
file on distribution and data availability along the period
and across the country. This review provides key ele-
ments to progress towards the control and interruption
of transmission of these diseases in the country, as a key
contributor to achieving the SGDs and ultimately
improving life of millions of people at risk.
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